指南与共识医学教育与科研方法临床试验与 GCP

试验保留中最重要的未解答研究问题是什么?James Lind Alliance优先级设定伙伴关系:PRioRiTy II(优先确定随机试验保留问题)研究

What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study.
指南 / 共识 · Trials · 2019-10-15

该优先级设定伙伴关系(PSP)与James Lind Alliance合作,通过三轮调查(初始在线调查、中期在线调查、面对面共识会议)确定并优先排序随机试验保留相关的未解答问题。初始调查456名受访者提供2431条回答,识别出372个保留相关问题,经主题分组和合并后产生27个问题进入中期评级,最终21个问题进入共识会议排序,本文报告前10位,排名第一的问题是「什么动机促使参与者决定完成临床试验」。

要点

  • 通过PSP方法确定了随机试验保留领域的Top 10未解答研究问题。
  • 排名第一的问题为「什么动机促使参与者决定完成临床试验?」
  • 完整列表可在www.priorityresearch.ie获取,可供资助者参考。

核心结论

  • Top 10列表可指导未来试验方法学研究方向,并供资助者用于指导旨在改善随机试验保留的项目。

研究设计与样本

  • 优先级设定伙伴关系(PSP),与James Lind Alliance合作,分三阶段:初始在线调查(6个开放式问题)、中期在线调查(从长列表中选取重要问题)、面对面共识会议(关键利益相关者代表排序)。
  • 初始调查共456名受访者,提供2431条回答,识别出372个专门关于保留的问题。
  • 经主题分组和与指导委员会协商合并问题后,产生27个问题进入中期调查评级。
  • 中期在线调查前21个问题进入面对面共识会议,关键利益相关者代表确定排序,本文报告前10位。

主要发现

  • 初始在线调查456名受访者提供2431条回答,识别出372个专门关于保留的问题。
  • 经分析产生27个问题进入中期调查评级,前21个问题进入共识会议排序。
  • 排名第一的问题为「什么动机促使参与者决定完成临床试验?」
  • 完整Top 10列表将在www.priorityresearch.ie公布。

临床怎么用

  • Top 10列表可供资助者用于指导旨在改善随机试验保留的项目。
  • Top 10列表可指导未来试验方法学研究方向。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: One of the top three research priorities for the UK clinical trial community is to address the gap in evidence-based approaches to improving participant retention in randomised trials. Despite this, there is little evidence supporting methods to improve retention. This paper reports the PRioRiTy II project, a Priority Setting Partnership (PSP) that identified and prioritised unanswered questions and uncertainties around trial retention in collaboration with key stakeholders. METHODS: This PSP was conducted in collaboration with the James Lind Alliance, a non-profit making initiative, to support key stakeholders (researchers, patients, and the public) in jointly identifying and agreeing on priority research questions. There were three stages. (1) First an initial online survey was conducted consisting of six open-ended questions about retention in randomised trials. Responses were coded into thematic groups to create a longlist of questions. The longlist of questions was checked against existing evidence to ensure that they had not been answered by existing research. (2) An interim stage involved a further online survey where stakeholders were asked to select questions of key importance from the longlist. (3) A face-to-face consensus meeting was held, where key stakeholder representatives agreed on an ordered list of 21 unanswered research questions for methods of improving retention in randomised trials. RESULTS: A total of 456 respondents yielded 2431 answers to six open-ended questions, from which 372 questions specifically about retention were identified. Further analysis included thematically grouping all data items within answers and merging questions in consultation with the Steering Group. This produced 27 questions for further rating during the interim survey. The top 21 questions from the interim online survey were brought to a face-to-face consensus meeting in which key stakeholder representatives prioritised the order. The 'Top 10' of these are reported in this paper. The number one ranked question was 'What motivates a participant's decision to complete a clinical trial?' The entire list will be available at www.priorityresearch.ie . CONCLUSION: The Top 10 list can inform the direction of future research on trial methods and be used by funders to guide projects aiming to address and improve retention in randomised trials.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Brunsdon E, Biesty L, Brocklehurst P, et al. What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study. Trials. 2019. PMID: 31615577. doi:10.1186/s13063-019-3687-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。